LEPTIN DEFICIENCY OR DYSFUNCTION
|
disease |
|
Disease or Syndrome
|
15
|
3
|
0.800 |
strong |
0.957 |
46 |
3
|
1996 |
2020 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.700 |
None |
0.952 |
794 |
7
|
1973 |
2020 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
620
|
64
|
0.700 |
None |
0.976 |
42 |
|
1997 |
2020 |
Hypogonadism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
305
|
24
|
0.650 |
None |
1.000 |
8 |
|
1998 |
2017 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.600 |
None |
0.952 |
124 |
2
|
1996 |
2020 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.600 |
None |
0.992 |
119 |
|
1976 |
2019 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.600 |
None |
0.972 |
71 |
2
|
1998 |
2020 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.600 |
None |
0.944 |
36 |
|
2004 |
2019 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.600 |
None |
1.000 |
31 |
|
2003 |
2020 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.600 |
None |
0.944 |
18 |
|
1996 |
2020 |
Hypercholesterolemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
489
|
123
|
0.540 |
None |
1.000 |
6 |
|
2012 |
2017 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.500 |
None |
1.000 |
5 |
|
2000 |
2014 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.500 |
None |
1.000 |
4 |
|
2003 |
2018 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.500 |
None |
1.000 |
3 |
|
2009 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
0.948 |
116 |
|
1999 |
2020 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.400 |
None |
0.948 |
116 |
|
1999 |
2020 |
Gestational Diabetes
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
649
|
224
|
0.400 |
None |
0.980 |
50 |
1
|
2000 |
2020 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.400 |
None |
1.000 |
38 |
|
2000 |
2020 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.400 |
None |
1.000 |
35 |
|
2009 |
2020 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.400 |
None |
0.906 |
32 |
|
1998 |
2019 |
Obesity, Morbid
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
203
|
49
|
0.400 |
None |
0.969 |
32 |
|
1997 |
2020 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.400 |
None |
1.000 |
27 |
|
2007 |
2019 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.400 |
None |
1.000 |
25 |
|
2009 |
2019 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.400 |
None |
1.000 |
24 |
|
2007 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.400 |
None |
1.000 |
22 |
|
1999 |
2018 |